Available 7 Days/Week       MON - FRI  8am - 7pm       SAT - SUN  10am – 6pm
Call us (239) 466-0400
Apply Now

Moderna asking for full FDA approval of its COVID vaccine

WASHINGTON / CNBC — Moderna officials asked the Food and Drug Administration to fully approve it’s coronavirus vaccine on Tuesday, making it the second drugmaker in the U.S. to do so.

If approved, Moderna would be able to market their vaccine directly to consumers.

The mRNA vaccine is currently on the U.S. market under an emergency use authorization, which was granted by the FDA in December. It gives conditional approval based on two months of safety data. It’s not the same as a biologics license application, or a request for full approval, which requires at least six months of data.

Over 100 million of the shots have already been administered, according to data from the Centers for Disease Control and Prevention.

“We are pleased to announce this important step in the U.S. regulatory process for a Biologics License Application of our COVID-19 vaccine,” Moderna CEO Stephane Bancel said. “We look forward to working with the FDA and will continue to submit data from our Phase 3 study and complete the rolling submission.”

Moderna will continue to submit data to support the BLA to the FDA on a rolling basis over the coming weeks, the company said Tuesday.

The FDA approval process is likely to take months.

Full U.S. approval will allow Moderna’s vaccine to stay on the market once the pandemic is over and the U.S. is no longer in a public health emergency, said former FDA commissioner Dr. Robert Califf. It also sets the stage for the company to begin advertising the shots on TV and other media platforms, he said, which is not allowed under an EUA.

If the FDA grants Moderna’s request, it would be the Massachusetts-based company’s first-ever approved product.

Moderna’s vaccine, which requires two doses given four weeks apart, is more than 90% effective at protecting against COVID and more than 95% effective against severe disease up to six months after the second dose, research shows.

The post Moderna asking for full FDA approval of its COVID vaccine appeared first on NBC2 News.

NBC2 (WBBH-TV)

#mortgagenaples, #naplesmortgage, #naplesnews, *Top News, Covid, Covid-19, Health, Moderna, National & World, News

mortgage lender, mortgage, naples mortgage, naples mortgage rates, napes mortgage company

*Assumes 2.799% APR, 20% down payment, and conforming 30-year fixed rate first mortgage on a single family, primary residence. The monthly payment you enter includes only principal and interest. Additional required amounts such as taxes, insurance, home owner association dues, assessments, mortgage insurance premiums, flood insurance or other such required payments should also be considered. Not all individuals will qualify for a mortgage loan based on the payment entered. Rates cited are for instructional purposes only; current rates are subject to change at any time without notice.  **Posted APR is based on Mortgage Assumptions
 
Copyright © 2021 Fidelity Home Group supports Equal Housing Opportunity | All Right Reserved  | NMLS Identifier 1834853. Fidelity Home Group is not affiliated with the Department of Housing and Urban Development (HUD) or the Federal Housing Administration (FHA). Not intended for legal or financial advice, consult your own professionals if such advice is sought. Accessibility Statement  | Consent to Receive Electronic Loan Documents  |  Cookies Policy   |  Disclosures  | Email and Mobile PolicyFair Lending Policy  |  Mortgage Assumptions  |  NMLS Consumer Access  |  Privacy Policy  |  Terms of Use 

Naples Mortgage | Fidelity Home Group
780 Fifth Avenue South, Suite 200, Naples, FL 34102

Hours of Operation:

Monday - Friday 8am to 7pm EST
Saturday - Sunday 10am to 6 pm EST

naples mortgage, naples mortgage rates, naples mortgage lender, naples mortgage broker, naples mortgage calculator, mortgage broker near me